Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2023-08-07 Director's Dealing
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Optomed Oyj - Johdon liiketoimet - Mäkinen
Director's Dealing Classification · 100% confidence The document is titled 'Johdon liiketoimet' (Management Transactions) and details a specific share transaction by a board member (Seppo Mäkinen) of Optomed Oyj. It includes standard fields for director dealings such as the person's name, position, instrument type (share), and transaction nature. This fits the definition of a Director's Dealing (DIRS) report.
2023-08-07 Finnish
Muutos Optomedin omien osakkeiden omistuksessa
Transaction in Own Shares Classification · 100% confidence The document is a stock exchange release (Pörssitiedote) from Optomed Oyj regarding changes in the company's holding of its own shares (treasury shares). It details the transfer of shares to board members as part of their remuneration and the issuance of shares from the company's treasury for an option program. This falls under the category of a company buying back or selling/transferring its own shares, which is classified as 'Transaction in Own Shares'.
2023-08-07 Finnish
Change in Optomed's holding of treasury shares
Transaction in Own Shares Classification · 98% confidence The document explicitly discusses a 'Change in Optomed's holding of treasury shares' where shares were conveyed to Board members as part of their annual remuneration and shares were subscribed for under a stock option plan. This action involves the company dealing in its own shares (treasury shares) for compensation and option fulfillment. This directly aligns with the definition of 'Transaction in Own Shares' (Code: POS), which covers share repurchase or issuance related to internal corporate actions like compensation.
2023-08-07 English
Muutos Optomedin omien osakkeiden omistuksessa
Transaction in Own Shares Classification · 98% confidence The document is a short official announcement (1508 characters) from Optomed Oyj, titled 'Muutokset omien osakkeiden omistuksessa' (Changes in Own Shares Holding). The text explicitly details the transfer of 15,093 treasury shares to board members as part of their annual remuneration and the subscription of 1,000 shares under an option program, followed by an update on the remaining treasury shares (353,973). This activity directly relates to the company buying back or issuing its own shares, which aligns perfectly with the definition of 'Transaction in Own Shares' (POS). It is not a comprehensive report (like 10-K or IR) nor a general announcement of a report (RPA/RNS), but a specific transaction disclosure.
2023-08-07 Finnish
Optomedin taloudellinen raportointi 2024
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1860 characters) from Optomed Oyj detailing the scheduled release dates for its 2024 financial reports (annual, interim, and half-year) and the planned date for the Annual General Meeting. It does not contain the actual financial results or reports themselves, but rather serves as a calendar notification for investors. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2023-08-04 Finnish
08042107.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-year report) for Optomed for the period January-June 2023. It contains comprehensive financial statements, segment analysis (Devices and Software), management commentary, and key performance indicators. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-04 Finnish

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.